{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T20:05:49Z","timestamp":1780344349644,"version":"3.54.1"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.soc.2013.02.010","type":"journal-article","created":{"date-parts":[[2013,3,19]],"date-time":"2013-03-19T12:20:52Z","timestamp":1363695652000},"page":"525-543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Radiation Therapy in Anal and Rectal Cancer"],"prefix":"10.1016","volume":"22","author":[{"given":"Brian G.","family":"Czito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.soc.2013.02.010_bib1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/1097-0142(19840701)54:1<114::AID-CNCR2820540124>3.0.CO;2-P","article-title":"Carcinoma of the anal canal. A clinical and pathologic study of 188 cases","volume":"54","author":"Boman","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2013.02.010_bib2","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF02586980","article-title":"Combined therapy for cancer of the anal canal: a preliminary report","volume":"17","author":"Nigro","year":"1974","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.soc.2013.02.010_bib3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/BF02586688","article-title":"Combined therapy for cancer of the anal canal: a follow-up report","volume":"20","author":"Buroker","year":"1977","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.soc.2013.02.010_bib4","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/1097-0142(19830201)51:3<390::AID-CNCR2820510306>3.0.CO;2-V","article-title":"Preoperative chemotherapy and radiation therapy in the management of anal epidermoid carcinoma","volume":"51","author":"Michaelson","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2013.02.010_bib5","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/1097-0142(19830515)51:10<1826::AID-CNCR2820511012>3.0.CO;2-L","article-title":"Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal","volume":"51","author":"Nigro","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2013.02.010_bib6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0002-9343(85)90428-0","article-title":"Cancer of the anal canal. Model for preoperative adjuvant combined modality therapy","volume":"78","author":"Leichman","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.soc.2013.02.010_bib7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/1097-0142(19860201)57:3<525::AID-CNCR2820570320>3.0.CO;2-V","article-title":"Combined chemotherapy, radiation, and surgery for epithelial cancer of the anal canal","volume":"57","author":"Meeker","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2013.02.010_bib8","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","article-title":"Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.soc.2013.02.010_bib9","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","article-title":"Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)","volume":"102","author":"Northover","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.soc.2013.02.010_bib10","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"Bartelink","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2013.02.010_bib11","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","article-title":"Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized Intergroup study","volume":"14","author":"Flam","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2013.02.010_bib12","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs. fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal. a randomized controlled trial","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.soc.2013.02.010_bib13","doi-asserted-by":"crossref","first-page":"180s","DOI":"10.1200\/jco.2006.24.18_suppl.4009","article-title":"Intergroup RTOG 98-11: a phase III randomized study of 5-fluoruracil (5-FU), mitomycin, and radiotherapy versus 5-fluorouracil, cisplatin and radiotherapy in carcinoma of the anal canal","volume":"24","author":"Ajani","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2013.02.010_bib14","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.ijrobp.2006.07.070","article-title":"Intergroup RTOG 9811 phase III comparison of chemoradiation with 5-FU and mitomycin vs. 5-FU and cisplatin for anal canal carcinoma: impact of disease-free, overall and colostomy-free survival","volume":"66","author":"Gunderson","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.soc.2013.02.010_bib15","article-title":"Long-term update of U.S. GI Intergroup RTOG-98-11 phase III trial for anal carcinoma: Comparison of concurrent chemoradiation with 5FU mitomycin versus 5FU-cisplatin for disease-free and overall survival","volume":"29","author":"Gunderson","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2013.02.010_bib16","doi-asserted-by":"crossref","first-page":"170s","DOI":"10.1200\/jco.2009.27.18_suppl.lba4009","article-title":"A\u00a0randomized trial of chemoradiation using mitomycin or cisplatin, with or without maintenance cisplatin\/5FU in squamous cell carcinoma of the anus (ACT II)","volume":"27","author":"James","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2013.02.010_bib17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11307-005-0003-6","article-title":"Positron emission tomography for pretreatment staging and post treatment evaluation in cancer of the anal canal","volume":"7","author":"Trautmann","year":"2005","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.soc.2013.02.010_bib18","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ijrobp.2006.01.009","article-title":"FDG-PET\/CT in the evaluation of anal carcinoma","volume":"65","author":"Cotter","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.soc.2013.02.010_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijrobp.2007.02.055","article-title":"PET-CT fusion in radiation management of patients with anorectal tumors","volume":"69","author":"Anderson","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.soc.2013.02.010_bib20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ijrobp.2010.05.050","article-title":"Contrast enhanced fluorodeoxyglucose-positron emission tomography\/computed tomography for staging and radiotherapy planning in patients with anal cancer","volume":"81","author":"Bannas","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.soc.2013.02.010_bib21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00384-010-1080-9","article-title":"Impact of FDG PET\/CT in the staging and the follow-up of anal carcinoma","volume":"26","author":"Vercellino","year":"2011","journal-title":"Int J Colorectal Dis"},{"issue":"1","key":"10.1016\/j.soc.2013.02.010_bib22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijrobp.2007.09.005","article-title":"Tumor response and survival predicted by post-therapy FDG-PET\/CT in anal cancer","volume":"71","author":"Schwarz","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.soc.2013.02.010_bib23","first-page":"194","article-title":"Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08","volume":"2","author":"John","year":"1996","journal-title":"Cancer J Sci Am"},{"key":"10.1016\/j.soc.2013.02.010_bib24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10350-007-9125-z","article-title":"Squamous-cell carcinoma of the anal canal: predictors of treatment outcome","volume":"51","author":"Roohipour","year":"2008","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.soc.2013.02.010_bib25","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1200\/JCO.2010.29.1351","article-title":"Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11","volume":"28","author":"Ben-Josef","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2013.02.010_bib26","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.1200\/JCO.2007.12.3133","article-title":"Neoadjuvant cisplatin chemotherapy before chemoradiation: a flawed paradigm","volume":"25","author":"Glynne-Jones","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2013.02.010_bib27","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1200\/JCO.2005.02.9793","article-title":"Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer","volume":"24","author":"De Ruysscher","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2013.02.010_bib28","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1200\/JCO.2005.04.9676","article-title":"Scheduling of radiation and chemotherapy for limited-stage small-cell lung cancer: repopulation as a cause of treatment failure?","volume":"24","author":"Brade","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2013.02.010_bib29","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1016\/j.ejca.2009.06.020","article-title":"Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014)","volume":"45","author":"Matzinger","year":"2009","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.soc.2013.02.010_bib30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.radonc.2012.06.006","article-title":"Three cytotoxic drugs combined with pelvic radiation and as maintenance chemotherapy for patients with squamous cell carcinoma of the anus (SCCA): long-term follow-up of a phase II pilot study using 5-fluorouracil, mitomycin C and cisplatin","volume":"104","author":"Sebag-Montefiore","year":"2012","journal-title":"Radiother Oncol"},{"issue":"16","key":"10.1016\/j.soc.2013.02.010_bib31","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2011.35.4837","article-title":"Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial","volume":"30","author":"Peiffert","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soc.2013.02.010_bib32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijrobp.2007.12.012","article-title":"EXTRA\u2013a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer","volume":"72","author":"Glynne-Jones","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl","key":"10.1016\/j.soc.2013.02.010_bib33","first-page":"15s","article-title":"Phase II study of capecitabine and oxaliplatin with concurrent radiation therapy (XELOX-XRT) for squamous cell carcinoma of the anal canal","volume":"27","author":"Eng","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2013.02.010_bib34","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1200\/JCO.2007.12.0170","article-title":"Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience","volume":"25","author":"Salama","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2013.02.010_bib35","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.ijrobp.2009.09.046","article-title":"Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis","volume":"78","author":"Pepek","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.soc.2013.02.010_bib36","article-title":"RTOG 0529: a phase II evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal cancer","author":"Kachnic","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 4","key":"10.1016\/j.soc.2013.02.010_bib37","article-title":"Two-year outcomes of RTOG 0529: A phase II evaluation of dose-painted IMRT in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal","volume":"29","author":"Kachnic","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.soc.2013.02.010_bib38","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ijrobp.2009.09.029","article-title":"Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation therapy planning","volume":"78","author":"Wright","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.soc.2013.02.010_bib39","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/S0140-6736(00)99076-7","article-title":"A\u00a0method for performing abdomino-perineal excision for carcinoma of the rectum and the terminal portion of the pelvic colon","volume":"II","author":"Miles","year":"1908","journal-title":"Lancet"},{"issue":"8496","key":"10.1016\/j.soc.2013.02.010_bib40","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0140-6736(86)91510-2","article-title":"Recurrence and survival after total mesorectal excision for rectal cancer","volume":"1","author":"Heald","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.soc.2013.02.010_bib41","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/BF00298532","article-title":"Analysis of local recurrence rates after surgery alone for rectal cancer","volume":"10","author":"McCall","year":"1995","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.soc.2013.02.010_bib42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jnci\/80.1.21","article-title":"Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: Results from NSABP protocol R-01","volume":"80","author":"Fisher","year":"1988","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.soc.2013.02.010_bib43","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/jnci\/92.5.388","article-title":"Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National surgical adjuvant breast and bowel project protocol R-02","volume":"92","author":"Wolmark","year":"2000","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.soc.2013.02.010_bib44","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJM198506063122301","article-title":"Gastrointestinal tumor study group. Prolongation of the disease-free interval in surgically treated rectal carcinoma","volume":"312","year":"1985","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.soc.2013.02.010_bib45","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199103143241101","article-title":"Effective surgical adjuvant therapy for high-risk rectal carcinoma","volume":"324","author":"Krook","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.soc.2013.02.010_bib46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/1097-0142(19900701)66:1<49::AID-CNCR2820660111>3.0.CO;2-1","article-title":"Stockholm rectal cancer study group. Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial","volume":"66","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2013.02.010_bib47","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1200\/JCO.2005.08.144","article-title":"Swedish rectal cancer trial: Long lasting benefits from radiotherapy on survival and local recurrence rate","volume":"23","author":"Folkesson","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"8514","key":"10.1016\/j.soc.2013.02.010_bib48","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0140-6736(86)92612-7","article-title":"Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumor spread and surgical excision","volume":"2","author":"Quirke","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.soc.2013.02.010_bib49","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/archsurg.133.8.894","article-title":"Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997","volume":"133","author":"Heald","year":"1998","journal-title":"Arch Surg"},{"issue":"6","key":"10.1016\/j.soc.2013.02.010_bib50","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial","volume":"12","author":"van Gijn","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.soc.2013.02.010_bib51","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1200\/JCO.2007.11.5287","article-title":"Antimetabolite radiosensitizers","volume":"25","author":"Shewach","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2013.02.010_bib52","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1200\/JCO.2006.06.7629","article-title":"Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203","volume":"24","author":"Gerard","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2013.02.010_bib53","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa060829","article-title":"Chemotherapy with preoperative radiotherapy in rectal cancer","volume":"355","author":"Bosset","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.soc.2013.02.010_bib54","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.soc.2013.02.010_bib55","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1200\/JCO.2009.22.0467","article-title":"Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R- 03","volume":"27","author":"Roh","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2013.02.010_bib56","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(09)60484-0","article-title":"Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C-16): a mutlicentre, randomised trial","volume":"373","author":"Sebag-Montefiore","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.soc.2013.02.010_bib57","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ijrobp.2007.03.046","article-title":"Moderately low alpha\/beta ratio for rectal cancer may best explain the outcome of three fractionation schedules of preoperative radiotherapy","volume":"69","author":"Suwinski","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.soc.2013.02.010_bib58","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/bjs.5506","article-title":"Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer","volume":"93","author":"Bujko","year":"2006","journal-title":"Br J Surg"},{"key":"10.1016\/j.soc.2013.02.010_bib59","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/bjs.6914","article-title":"Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer","volume":"97","author":"Pettersson","year":"2010","journal-title":"Br J Surg"},{"key":"10.1016\/j.soc.2013.02.010_bib60","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0360-3016(01)01610-8","article-title":"T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment","volume":"51","author":"Sanfilippo","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.soc.2013.02.010_bib61","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/01.sla.0000141194.27992.32","article-title":"Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results","volume":"240","author":"Habr-Gama","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.soc.2013.02.010_bib62","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0959-8049(98)00058-6","article-title":"Design of a novel fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue","volume":"34","author":"Miwa","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.soc.2013.02.010_bib63","first-page":"814","article-title":"Neoadjuvant chemoradiation for rectal cancer: is more better?","volume":"22","author":"Patel","year":"2008","journal-title":"Oncology"},{"issue":"6","key":"10.1016\/j.soc.2013.02.010_bib64","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1470-2045(12)70116-X","article-title":"Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase III trial","volume":"13","author":"Hofheinz","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.soc.2013.02.010_bib65","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.canrad.2007.12.006","article-title":"Combining radiation with oxaliplatin: a review of experimental results","volume":"12","author":"Hermann","year":"2008","journal-title":"Cancer Radiother"},{"issue":"36","key":"10.1016\/j.soc.2013.02.010_bib66","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1200\/JCO.2012.42.8771","article-title":"Clinical outcome of the ACCORD 12\/0405 PRODIGE 2 randomized trial in rectal cancer","volume":"30","author":"Gerard","year":"2012","journal-title":"J Clin Oncol"},{"issue":"20","key":"10.1016\/j.soc.2013.02.010_bib67","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1200\/JCO.2010.34.4911","article-title":"Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial","volume":"29","author":"Aschele","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soc.2013.02.010_bib68","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1535-6108(04)00115-1","article-title":"Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules","volume":"5","author":"Moeller","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.soc.2013.02.010_bib69","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.soc.2013.02.010_bib70","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1200\/JCO.2008.21.1771","article-title":"Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study","volume":"27","author":"Willett","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2013.02.010_bib71","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ijrobp.2009.02.037","article-title":"Phase II trial of neoadjuvant bevacizumab, capecitabine,\u00a0and radiotherapy for locally advanced rectal cancer","volume":"76","author":"Crane","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.soc.2013.02.010_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.27890","article-title":"Phase II study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-FU, leucovorin, oxaliplatin (FOLFOX) and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204","author":"Landry","year":"2013","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.soc.2013.02.010_bib73","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/SLA.0b013e3182196e1f","article-title":"Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial","volume":"254","author":"Garcia-Aguilar","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.soc.2013.02.010_bib74","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0360-3016(01)01820-X","article-title":"The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer","volume":"52","author":"Baglan","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.soc.2013.02.010_bib75","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00384-006-0166-x","article-title":"Intensity-modulated radiotherapy with a belly board for rectal cancer","volume":"22","author":"Kim","year":"2007","journal-title":"Int J Colorectal Dis"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320713000227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320713000227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T11:58:25Z","timestamp":1760961505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320713000227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1055320713000227"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2013.02.010","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation Therapy in Anal and Rectal Cancer","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2013.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}